Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer

The purpose of this study was to evaluate whether tumour response to primary chemotherapy in human breast cancer is influenced by baseline haemoglobin (Hb) status. A total of 157 patients with T2-4, N0-1 M0 breast cancer were treated with chemotherapy consisting of either the CMF regimen + tamoxifen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bottini, A, Berruti, A, Brizzi, M P, Bersiga, A, Generali, D, Allevi, G, Aguggini, S, Bolsi, G, Bonardi, S, Bertoli, G, Alquati, P, Dogliotti, L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376950/
https://www.ncbi.nlm.nih.gov/pubmed/12966412
http://dx.doi.org/10.1038/sj.bjc.6601216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376950/
https://www.ncbi.nlm.nih.gov/pubmed/12966412
http://dx.doi.org/10.1038/sj.bjc.6601216

Ejemplares similares